bexmarilimab
faron pharmaceuticals
['melanoma', 'faron']
faron are presenting results from the melanoma cohort in the ongoing phase i/ii matins trial at the 19th international congress of the society for melanoma research, being held from october 17-20, 2022. read more here: #societyformelanomaresearch 
Faron is a clinical stage biopharmaceutical company focused on harnessing the power of the immune system in order to tackle cancer and inflammation.